Circle Acquires IBM Blockchain Patent Portfolio

iconChainthink
Share
This is the logo of the coin.
CRCL
----
AI summary iconSummary
Circle has acquired IBM’s core blockchain patent portfolio, according to blockchain news from Chainthink. The deal includes over 680 patent families and nearly 1,000 granted patents, covering blockchain fundamentals, finance, insurance, and enterprise infrastructure. This acquisition makes Circle the largest holder of blockchain patents in the U.S. The assets will support USDC, the Circle Payments Network, and Arc. A blockchain upgrade is anticipated as the company expands its on-chain tools. Circle and IBM will also explore new business opportunities.

ChainThink reports that on July 27, according to an official announcement, Circle Internet Group (NYSE: CRCL) announced the acquisition of core assets from IBM’s blockchain patent portfolio.

This portfolio includes over 680 patent families and nearly 1,000 granted patents, covering blockchain foundational technologies, banking, financial services, insurance, enterprise infrastructure, supply chain verification, and secure cloud operations.

Circle stated that, following the acquisition, it became the company with the most blockchain patents in the United States.

The expanded intellectual property will support the infrastructure for on-chain products and agent-based financial tools such as USDC, the Circle Payments Network, and Arc. Circle and IBM also plan to explore additional business collaboration opportunities.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.